Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. Common Stock (NY:OGN)

8.925 -0.095 (-1.05%)
Streaming Delayed Price Updated: 12:02 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio. 
Via The Motley Fool
Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals
From Organon & Co.
Via Business Wire
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Organon's Return On Capital Employed Insights
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Organon's Earnings: A Preview
Via Benzinga
Organon: Dividend Insights
Via Benzinga
Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health
From Organon & Co.
Via Business Wire
7 Stocks That Are Long Overdue for a Relief Rally
Here are seven stocks with the catalysts and fundamentals to support a sustained relief rally in this environment. 
Via InvestorPlace
Daily Stock Analysis: Organon & Co
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions. 
Via Talk Markets
Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Why Shares of Organon Fell 15% Thursday
The company reported fourth-quarter and year-end financials. 
Via The Motley Fool
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
Earnings Preview For Organon
Via Benzinga
Organon Reports Results for the First Quarter Ended March 31, 2023
From Organon & Co.
Via Business Wire
Organon To Report First Quarter and Host Conference Call on May 4, 2023
From Organon & Co.
Via Business Wire
7 Growth Stocks That Are Trading at a Bargain Price
Some analysts suggest that equities are in the beginning of a bull market. If so, now is a good time to look at buying bargain growth stocks. 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
Via Benzinga
Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
From Organon & Co.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's morning session saw 84 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash. 
Via Benzinga
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022
From Organon
Via Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023
From Organon & Co.
Via Business Wire
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
Amgen launched its biosimilar knockoff on Tuesday at a steep discount. 
Via Investor's Business Daily
'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) is the only China stock he would buy. 
Via Benzinga
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
Organon sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
From Organon & Co.
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.